A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer Therapy

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
To evaluate the efficacy and safety of Hetrombopag in secondary prevention of thrombocytopenia caused by lung cancer treatment
Epistemonikos ID: 22c7bbfbb1adc7f72fd83965d599f0957a8cf7ac
First added on: Aug 05, 2025